Alpine Bank Wealth Management’s Boston Scientific BSX Stock Holding History

Alpine Bank Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-340	Closed	-$33.2K	–	180
2025 Q3	$33.2K	Buy	+340	New	+$35.2K	﹤0.01%	260

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Alpine Bank Wealth Management's BSX Position: Q4 2025 in Review

Alpine Bank Wealth Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 340 shares — an estimated $33.2K sold.

Alpine Bank Wealth Management first reported a position in BSX in Q3 2025 and held it in 1 quarter. The position peaked at $33.2K in Q3 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Alpine Bank Wealth Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Alpine Bank Wealth Management sold 340 Boston Scientific shares in Q4 2025, an estimated $33.2K.
Alpine Bank Wealth Management first reported a position in Boston Scientific in Q3 2025 and held it in 1 quarter.
Alpine Bank Wealth Management's Boston Scientific position peaked at $33.2K in Q3 2025.
1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Alpine Bank Wealth Management's 13F filing for Q4 2025, filed 15 Jan 2026.